CAPTRUST Financial Advisors
MRNA icon

CAPTRUST Financial Advisors’s Moderna MRNA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105K Buy
+1,500
New +$77.6K ﹤0.01% 3033
2023
Q4 		– Sell
-500
Closed -$52 – 2751
2023
Q3 		$52 Buy
+500
New +$55.8K ﹤0.01% 2606

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

CAPTRUST Financial Advisors's MRNA Position: Q2 2026 in Review

CAPTRUST Financial Advisors increased its Moderna (MRNA) stake by 32% in Q2 2026, buying an estimated $175K and bringing the position to 14,041 shares worth $983K. The position accounts for ﹤0.01% of the portfolio, ranked #1752.

CAPTRUST Financial Advisors first reported a position in MRNA in Q4 2019 and has held it in 25 quarters since. The position peaked at $5.47M in Q3 2021. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • CAPTRUST Financial Advisors held 14,041 shares of Moderna worth $983K as of Q2 2026.
  • CAPTRUST Financial Advisors bought 3,387 Moderna shares in Q2 2026, an estimated $175K.
  • Moderna made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1752 holding.
  • CAPTRUST Financial Advisors first reported a position in Moderna in Q4 2019 and has held it in 25 quarters since.
  • CAPTRUST Financial Advisors's Moderna position peaked at $5.47M in Q3 2021.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.